← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oncotab, Inc
Charlotte, NC
$1,543,049
Total funding
5
Grants
Funding over time
peak $660.6K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,543,049 · 5
By mechanism
R41$1,243,049 · 4
N43$300,000 · 1
Investigators at Oncotab, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
An integrated strategy using a serum and imaging biomarker for the early detection of pancreatic cancer.$400,000
R41 · FY2021 · CA
Optimized targeted radiotherapy of pancreatic cancer$400,000
R41 · FY2025 · CA
IGF::OT::IGF DEVELOPMENT OF TARGETED RADIONUCLIDE THERAPY USING TUMOR SPECIFIC ANTIBODY FOR TRIPLE NEGATIVE BREAST CANCER$300,000
N43 · FY2016 · CA
The use of tMUC1/CD3 bispecific antibody to control pancreatic ductal adenocarcinoma$260,588
R41 · FY2021 · CA
Novel immunotherapy strategy for treatment of pancreatic cancer$182,461
R41 · FY2016 · CA